Solid Biosciences reposted this
Solid Biosciences, a leader in precision genetic medicines for neuromuscular and cardiac diseases is celebrating its inclusion in the Russell 3000® Index, effective July 1st, 2024! Solid Biosciences, a client at The Hub, acquired #OrigiGator and former client AavantiBio. This recognition highlights Solid Biosciences' growth and market impact following its acquisition of AavantiBio and ownership of multiple University of Florida technology licenses. It reflects progress in executing pipeline initiatives and brings the company enhanced exposure within the financial community. Read more at: https://lnkd.in/e22QDKZc